Title: On the loss of the phosphorylcholine‐based DES coating on the abluminal surface of endeavor stents
Abstract: Catheterization and Cardiovascular InterventionsVolume 76, Issue 1 p. 158-159 Letter to the Editor On the loss of the phosphorylcholine-based DES coating on the abluminal surface of endeavor stents† Clemens von Birgelen MD, PhD, Clemens von Birgelen MD, PhD Department of Cardiology, Thoraxcentrum Twente, Enschede, The Netherlands MIRA-Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The NetherlandsSearch for more papers by this authorMounir W.Z. Basalus MD, Mounir W.Z. Basalus MD Department of Cardiology, Thoraxcentrum Twente, Enschede, The NetherlandsSearch for more papers by this author Clemens von Birgelen MD, PhD, Clemens von Birgelen MD, PhD Department of Cardiology, Thoraxcentrum Twente, Enschede, The Netherlands MIRA-Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The NetherlandsSearch for more papers by this authorMounir W.Z. Basalus MD, Mounir W.Z. Basalus MD Department of Cardiology, Thoraxcentrum Twente, Enschede, The NetherlandsSearch for more papers by this author First published: 24 June 2010 https://doi.org/10.1002/ccd.22497Citations: 3 † Conflict of interest: The authors have no personal conflict of interest. The research department of Thoraxcentrum Enschede has received in the past unrestricted research grants and/or has participated in clinical studies funded by: Abbott Vascular, Biosensors International, Biotronik, Boston Scientific, Cordis Corporation, and Medtronic. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Wiemer M,Butz T,Schmidt W,Schmitz KP,Horstkotte D,Langer C. Scanning electron microscopic analysis of different drug-eluting stents after failed implantation: From nearly undamaged to major damaged polymer. Cathet Cardiovasc Interv, in press; DOI 10.1002/ccd. 21373. 2 Ormiston JA,Webster M,Ruygrok P. Polymer integrity after Cypher and Taxus stent implantation: A scanning electron microscope study. Presented at TCT, Washington, D.C., 2004; Available at: http://www. tctmd.com. 3 Otsuka Y,Chronos NA,Apkarian RP,Robinson KA. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 2007; 19: 71–76. 4 Basalus MW,Ankone MJ,van Houwelingen GK,de Man FH,von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroInterv 2009; 5: 157–165. 5 Leon MB. Endeavor IV-A randomized comparison of a zotarolimus-eluting stent endeavor IV-A randomized comparison of a zotarolimus-eluting stent. Presented at TCT, Washington, D.C., 2007; Available at: http://www.tctmd.com. 6 Kirtane AJ,Patel R,O'Shaughnessy C,Overlie P,McLaurin B,Solomon S,Mauri L,Fitzgerald P,Popma JJ,Kandzari DE,Leon MB. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: Randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv 2009; 2: 967–976. Citing Literature Volume76, Issue11 July 2010Pages 158-159 SCAI Member Sign in ReferencesRelatedInformation